Essential role of ATP6AP2 enrichment in caveolae/lipid raft microdomains for the induction of neuronal differentiation of stem cells
Background The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal di...
Saved in:
Published in | Stem cell research & therapy Vol. 9; no. 1; pp. 132 - 24 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
11.05.2018
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1757-6512 1757-6512 |
DOI | 10.1186/s13287-018-0862-9 |
Cover
Loading…
Abstract | Background
The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal differentiation (Neu-
Dif
) of adipose-derived mesenchymal stem cells (ADSCs).
Methods
Human ADSCs isolated from 24 healthy donors and 24 patients with neurological disorders (ND) were cultured and induced for Neu-
Dif
. The mechanism of action of ATP6AP2 and the impact of its localization within the plasma membrane (particularly CLR-Ms) and intracellular sites on several pathways (mitogen-activated protein kinase, Wnt(s) signaling and others) and intracellular calcium and exosome release were evaluated. The impact of CLR-Ms on ATP6AP2 or vice versa was determined by pharmacological disruption of CLR-Ms or siATP6AP2 assays.
Results
In patients with ND, loss of ATP6AP2 from CLR-Ms correlated with an inhibition of Neu-
Dif
and signaling. However, its relocalization in CLR-Ms was positively correlated to induction of Neu-
Dif
in healthy subjects
.
An apparent switch from canonical to noncanonical Wnt signaling as well as from caveolin to flotillin occurs concurrently with the increases of ATP6AP2 expression during neurogenesis. Stimulation by renin activates ERK/JNK/CREB/c-Jun but failed to induce β-catenin. Wnt5a enhanced the renin-induced JNK responsiveness. Gα proteins crosslink ATP6AP2 to caveolin where a switch from Gαi to Gαq is necessary for Neu-
Dif
. In ATP6AP2-enriched CLR-Ms, the release of exosomes was induced dependently from the intracellular Ca
2+
and Gαq. Pharmacological disruption of CLR-M formation/stability impairs both ATP6AP2 localization and Neu-
Dif
in addition to reducing exosome release, indicating an essential role of ATP6AP2 enrichment in CLR-Ms for the induction of Neu-
Dif
. The mechanism is dependent on CLR-M dynamics, particularly the membrane fluidity. Knockdown of ATP6AP2 inhibited Neu-
Dif
but increased astrocytic-
Dif
, depleted ATP6AP2/flotillin/Gαq but accumulated caveolin/Gαi in CLR-Ms, and blocked the activation of JNK/ERK/c-Jun/CREB/exosome release. siATP6AP2 cells treated with sphingomyelinase/methyl-β-cyclodextrin reversed the levels of caveolin/flotillin in CLR-Ms but did not induce Neu-
Dif
, indicating the crucial relocalization of ATP6AP2 in CLR-Ms for neurogenesis. Treatment of ND-derived cells with nSMase showed reversibility in ATP6AP2 abundance in CLR-Ms and enhanced Neu-
Dif.
Conclusions
This study gives evidence of the determinant role of CLR-M ATP6AP2 localization for neuronal and oligodendrocyte differentiation involving mechanisms of switches from Gαi/caveolin/canonical to Gαq/flotillin/PCP, the ERK/JNK pathway and Ca
2+
-dependent release of exosomes and as a potential target of drug therapy for neurodegenerative disorders. |
---|---|
AbstractList | The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal differentiation (Neu-Dif) of adipose-derived mesenchymal stem cells (ADSCs).
Human ADSCs isolated from 24 healthy donors and 24 patients with neurological disorders (ND) were cultured and induced for Neu-Dif. The mechanism of action of ATP6AP2 and the impact of its localization within the plasma membrane (particularly CLR-Ms) and intracellular sites on several pathways (mitogen-activated protein kinase, Wnt(s) signaling and others) and intracellular calcium and exosome release were evaluated. The impact of CLR-Ms on ATP6AP2 or vice versa was determined by pharmacological disruption of CLR-Ms or siATP6AP2 assays.
In patients with ND, loss of ATP6AP2 from CLR-Ms correlated with an inhibition of Neu-Dif and signaling. However, its relocalization in CLR-Ms was positively correlated to induction of Neu-Dif in healthy subjects. An apparent switch from canonical to noncanonical Wnt signaling as well as from caveolin to flotillin occurs concurrently with the increases of ATP6AP2 expression during neurogenesis. Stimulation by renin activates ERK/JNK/CREB/c-Jun but failed to induce β-catenin. Wnt5a enhanced the renin-induced JNK responsiveness. Gα proteins crosslink ATP6AP2 to caveolin where a switch from Gαi to Gαq is necessary for Neu-Dif. In ATP6AP2-enriched CLR-Ms, the release of exosomes was induced dependently from the intracellular Ca
and Gαq. Pharmacological disruption of CLR-M formation/stability impairs both ATP6AP2 localization and Neu-Dif in addition to reducing exosome release, indicating an essential role of ATP6AP2 enrichment in CLR-Ms for the induction of Neu-Dif. The mechanism is dependent on CLR-M dynamics, particularly the membrane fluidity. Knockdown of ATP6AP2 inhibited Neu-Dif but increased astrocytic-Dif, depleted ATP6AP2/flotillin/Gαq but accumulated caveolin/Gαi in CLR-Ms, and blocked the activation of JNK/ERK/c-Jun/CREB/exosome release. siATP6AP2 cells treated with sphingomyelinase/methyl-β-cyclodextrin reversed the levels of caveolin/flotillin in CLR-Ms but did not induce Neu-Dif, indicating the crucial relocalization of ATP6AP2 in CLR-Ms for neurogenesis. Treatment of ND-derived cells with nSMase showed reversibility in ATP6AP2 abundance in CLR-Ms and enhanced Neu-Dif.
This study gives evidence of the determinant role of CLR-M ATP6AP2 localization for neuronal and oligodendrocyte differentiation involving mechanisms of switches from Gαi/caveolin/canonical to Gαq/flotillin/PCP, the ERK/JNK pathway and Ca
-dependent release of exosomes and as a potential target of drug therapy for neurodegenerative disorders. Background The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal differentiation (Neu- Dif ) of adipose-derived mesenchymal stem cells (ADSCs). Methods Human ADSCs isolated from 24 healthy donors and 24 patients with neurological disorders (ND) were cultured and induced for Neu- Dif . The mechanism of action of ATP6AP2 and the impact of its localization within the plasma membrane (particularly CLR-Ms) and intracellular sites on several pathways (mitogen-activated protein kinase, Wnt(s) signaling and others) and intracellular calcium and exosome release were evaluated. The impact of CLR-Ms on ATP6AP2 or vice versa was determined by pharmacological disruption of CLR-Ms or siATP6AP2 assays. Results In patients with ND, loss of ATP6AP2 from CLR-Ms correlated with an inhibition of Neu- Dif and signaling. However, its relocalization in CLR-Ms was positively correlated to induction of Neu- Dif in healthy subjects . An apparent switch from canonical to noncanonical Wnt signaling as well as from caveolin to flotillin occurs concurrently with the increases of ATP6AP2 expression during neurogenesis. Stimulation by renin activates ERK/JNK/CREB/c-Jun but failed to induce β-catenin. Wnt5a enhanced the renin-induced JNK responsiveness. Gα proteins crosslink ATP6AP2 to caveolin where a switch from Gαi to Gαq is necessary for Neu- Dif . In ATP6AP2-enriched CLR-Ms, the release of exosomes was induced dependently from the intracellular Ca 2+ and Gαq. Pharmacological disruption of CLR-M formation/stability impairs both ATP6AP2 localization and Neu- Dif in addition to reducing exosome release, indicating an essential role of ATP6AP2 enrichment in CLR-Ms for the induction of Neu- Dif . The mechanism is dependent on CLR-M dynamics, particularly the membrane fluidity. Knockdown of ATP6AP2 inhibited Neu- Dif but increased astrocytic- Dif , depleted ATP6AP2/flotillin/Gαq but accumulated caveolin/Gαi in CLR-Ms, and blocked the activation of JNK/ERK/c-Jun/CREB/exosome release. siATP6AP2 cells treated with sphingomyelinase/methyl-β-cyclodextrin reversed the levels of caveolin/flotillin in CLR-Ms but did not induce Neu- Dif , indicating the crucial relocalization of ATP6AP2 in CLR-Ms for neurogenesis. Treatment of ND-derived cells with nSMase showed reversibility in ATP6AP2 abundance in CLR-Ms and enhanced Neu- Dif. Conclusions This study gives evidence of the determinant role of CLR-M ATP6AP2 localization for neuronal and oligodendrocyte differentiation involving mechanisms of switches from Gαi/caveolin/canonical to Gαq/flotillin/PCP, the ERK/JNK pathway and Ca 2+ -dependent release of exosomes and as a potential target of drug therapy for neurodegenerative disorders. Abstract Background The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal differentiation (Neu-Dif) of adipose-derived mesenchymal stem cells (ADSCs). Methods Human ADSCs isolated from 24 healthy donors and 24 patients with neurological disorders (ND) were cultured and induced for Neu-Dif. The mechanism of action of ATP6AP2 and the impact of its localization within the plasma membrane (particularly CLR-Ms) and intracellular sites on several pathways (mitogen-activated protein kinase, Wnt(s) signaling and others) and intracellular calcium and exosome release were evaluated. The impact of CLR-Ms on ATP6AP2 or vice versa was determined by pharmacological disruption of CLR-Ms or siATP6AP2 assays. Results In patients with ND, loss of ATP6AP2 from CLR-Ms correlated with an inhibition of Neu-Dif and signaling. However, its relocalization in CLR-Ms was positively correlated to induction of Neu-Dif in healthy subjects. An apparent switch from canonical to noncanonical Wnt signaling as well as from caveolin to flotillin occurs concurrently with the increases of ATP6AP2 expression during neurogenesis. Stimulation by renin activates ERK/JNK/CREB/c-Jun but failed to induce β-catenin. Wnt5a enhanced the renin-induced JNK responsiveness. Gα proteins crosslink ATP6AP2 to caveolin where a switch from Gαi to Gαq is necessary for Neu-Dif. In ATP6AP2-enriched CLR-Ms, the release of exosomes was induced dependently from the intracellular Ca2+ and Gαq. Pharmacological disruption of CLR-M formation/stability impairs both ATP6AP2 localization and Neu-Dif in addition to reducing exosome release, indicating an essential role of ATP6AP2 enrichment in CLR-Ms for the induction of Neu-Dif. The mechanism is dependent on CLR-M dynamics, particularly the membrane fluidity. Knockdown of ATP6AP2 inhibited Neu-Dif but increased astrocytic-Dif, depleted ATP6AP2/flotillin/Gαq but accumulated caveolin/Gαi in CLR-Ms, and blocked the activation of JNK/ERK/c-Jun/CREB/exosome release. siATP6AP2 cells treated with sphingomyelinase/methyl-β-cyclodextrin reversed the levels of caveolin/flotillin in CLR-Ms but did not induce Neu-Dif, indicating the crucial relocalization of ATP6AP2 in CLR-Ms for neurogenesis. Treatment of ND-derived cells with nSMase showed reversibility in ATP6AP2 abundance in CLR-Ms and enhanced Neu-Dif. Conclusions This study gives evidence of the determinant role of CLR-M ATP6AP2 localization for neuronal and oligodendrocyte differentiation involving mechanisms of switches from Gαi/caveolin/canonical to Gαq/flotillin/PCP, the ERK/JNK pathway and Ca2+-dependent release of exosomes and as a potential target of drug therapy for neurodegenerative disorders. The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal differentiation (Neu-Dif) of adipose-derived mesenchymal stem cells (ADSCs).BACKGROUNDThe subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression and subcellular relocalization from caveolae/lipid raft microdomains (CLR-Ms) to intracellular sites may correlate with neuronal differentiation (Neu-Dif) of adipose-derived mesenchymal stem cells (ADSCs).Human ADSCs isolated from 24 healthy donors and 24 patients with neurological disorders (ND) were cultured and induced for Neu-Dif. The mechanism of action of ATP6AP2 and the impact of its localization within the plasma membrane (particularly CLR-Ms) and intracellular sites on several pathways (mitogen-activated protein kinase, Wnt(s) signaling and others) and intracellular calcium and exosome release were evaluated. The impact of CLR-Ms on ATP6AP2 or vice versa was determined by pharmacological disruption of CLR-Ms or siATP6AP2 assays.METHODSHuman ADSCs isolated from 24 healthy donors and 24 patients with neurological disorders (ND) were cultured and induced for Neu-Dif. The mechanism of action of ATP6AP2 and the impact of its localization within the plasma membrane (particularly CLR-Ms) and intracellular sites on several pathways (mitogen-activated protein kinase, Wnt(s) signaling and others) and intracellular calcium and exosome release were evaluated. The impact of CLR-Ms on ATP6AP2 or vice versa was determined by pharmacological disruption of CLR-Ms or siATP6AP2 assays.In patients with ND, loss of ATP6AP2 from CLR-Ms correlated with an inhibition of Neu-Dif and signaling. However, its relocalization in CLR-Ms was positively correlated to induction of Neu-Dif in healthy subjects. An apparent switch from canonical to noncanonical Wnt signaling as well as from caveolin to flotillin occurs concurrently with the increases of ATP6AP2 expression during neurogenesis. Stimulation by renin activates ERK/JNK/CREB/c-Jun but failed to induce β-catenin. Wnt5a enhanced the renin-induced JNK responsiveness. Gα proteins crosslink ATP6AP2 to caveolin where a switch from Gαi to Gαq is necessary for Neu-Dif. In ATP6AP2-enriched CLR-Ms, the release of exosomes was induced dependently from the intracellular Ca2+ and Gαq. Pharmacological disruption of CLR-M formation/stability impairs both ATP6AP2 localization and Neu-Dif in addition to reducing exosome release, indicating an essential role of ATP6AP2 enrichment in CLR-Ms for the induction of Neu-Dif. The mechanism is dependent on CLR-M dynamics, particularly the membrane fluidity. Knockdown of ATP6AP2 inhibited Neu-Dif but increased astrocytic-Dif, depleted ATP6AP2/flotillin/Gαq but accumulated caveolin/Gαi in CLR-Ms, and blocked the activation of JNK/ERK/c-Jun/CREB/exosome release. siATP6AP2 cells treated with sphingomyelinase/methyl-β-cyclodextrin reversed the levels of caveolin/flotillin in CLR-Ms but did not induce Neu-Dif, indicating the crucial relocalization of ATP6AP2 in CLR-Ms for neurogenesis. Treatment of ND-derived cells with nSMase showed reversibility in ATP6AP2 abundance in CLR-Ms and enhanced Neu-Dif.RESULTSIn patients with ND, loss of ATP6AP2 from CLR-Ms correlated with an inhibition of Neu-Dif and signaling. However, its relocalization in CLR-Ms was positively correlated to induction of Neu-Dif in healthy subjects. An apparent switch from canonical to noncanonical Wnt signaling as well as from caveolin to flotillin occurs concurrently with the increases of ATP6AP2 expression during neurogenesis. Stimulation by renin activates ERK/JNK/CREB/c-Jun but failed to induce β-catenin. Wnt5a enhanced the renin-induced JNK responsiveness. Gα proteins crosslink ATP6AP2 to caveolin where a switch from Gαi to Gαq is necessary for Neu-Dif. In ATP6AP2-enriched CLR-Ms, the release of exosomes was induced dependently from the intracellular Ca2+ and Gαq. Pharmacological disruption of CLR-M formation/stability impairs both ATP6AP2 localization and Neu-Dif in addition to reducing exosome release, indicating an essential role of ATP6AP2 enrichment in CLR-Ms for the induction of Neu-Dif. The mechanism is dependent on CLR-M dynamics, particularly the membrane fluidity. Knockdown of ATP6AP2 inhibited Neu-Dif but increased astrocytic-Dif, depleted ATP6AP2/flotillin/Gαq but accumulated caveolin/Gαi in CLR-Ms, and blocked the activation of JNK/ERK/c-Jun/CREB/exosome release. siATP6AP2 cells treated with sphingomyelinase/methyl-β-cyclodextrin reversed the levels of caveolin/flotillin in CLR-Ms but did not induce Neu-Dif, indicating the crucial relocalization of ATP6AP2 in CLR-Ms for neurogenesis. Treatment of ND-derived cells with nSMase showed reversibility in ATP6AP2 abundance in CLR-Ms and enhanced Neu-Dif.This study gives evidence of the determinant role of CLR-M ATP6AP2 localization for neuronal and oligodendrocyte differentiation involving mechanisms of switches from Gαi/caveolin/canonical to Gαq/flotillin/PCP, the ERK/JNK pathway and Ca2+-dependent release of exosomes and as a potential target of drug therapy for neurodegenerative disorders.CONCLUSIONSThis study gives evidence of the determinant role of CLR-M ATP6AP2 localization for neuronal and oligodendrocyte differentiation involving mechanisms of switches from Gαi/caveolin/canonical to Gαq/flotillin/PCP, the ERK/JNK pathway and Ca2+-dependent release of exosomes and as a potential target of drug therapy for neurodegenerative disorders. |
ArticleNumber | 132 |
Audience | Academic |
Author | Ismail, Bassel Ayoub, David Makdissy, Nehman Oreibi, Ghada Azar, Albert Quilliot, Didier Fajloun, Ziad Haddad, Katia Achkar, Ibrahim AlBacha, Jeanne D’arc Chaker, Diana |
Author_xml | – sequence: 1 givenname: Nehman orcidid: 0000-0001-7240-0968 surname: Makdissy fullname: Makdissy, Nehman email: almakdissy@hotmail.com organization: Department of Biology, Lebanese University, Faculty of Sciences III – sequence: 2 givenname: Katia surname: Haddad fullname: Haddad, Katia organization: Department of Biology, Lebanese University, Faculty of Sciences III – sequence: 3 givenname: Jeanne D’arc surname: AlBacha fullname: AlBacha, Jeanne D’arc organization: Doctoral School for Sciences and Technology, Azm Center for the Research in Biotechnology and its Applications, Lebanese University – sequence: 4 givenname: Diana surname: Chaker fullname: Chaker, Diana organization: Doctoral School for Sciences and Technology, Azm Center for the Research in Biotechnology and its Applications, Lebanese University – sequence: 5 givenname: Bassel surname: Ismail fullname: Ismail, Bassel organization: Doctoral School for Sciences and Technology, Faculty of Sciences I, Lebanese University – sequence: 6 givenname: Albert surname: Azar fullname: Azar, Albert organization: Reviva Regenerative Medicine Center, Human Genetic Center, Middle East Institute of Health Hospital – sequence: 7 givenname: Ghada surname: Oreibi fullname: Oreibi, Ghada organization: Reviva Regenerative Medicine Center, Human Genetic Center, Middle East Institute of Health Hospital – sequence: 8 givenname: David surname: Ayoub fullname: Ayoub, David organization: Ayoub Clinic Lebanon and Department of Neuroloradiology, Limoges University Hospital – sequence: 9 givenname: Ibrahim surname: Achkar fullname: Achkar, Ibrahim organization: Achkar Clinics, St. Elie Center – sequence: 10 givenname: Didier surname: Quilliot fullname: Quilliot, Didier organization: Diabetologia-Endocrinology & Nutrition, CHRU Nancy, INSERM 954, University Henri Poincaré, Faculty of Medicine – sequence: 11 givenname: Ziad surname: Fajloun fullname: Fajloun, Ziad organization: Department of Biology, Lebanese University, Faculty of Sciences III, Doctoral School for Sciences and Technology, Azm Center for the Research in Biotechnology and its Applications, Lebanese University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29751779$$D View this record in MEDLINE/PubMed |
BookMark | eNp9klFr1TAYhotM3Jz7Ad5IQRC96NakadLeDA5j6oGBQ-d1yEm-npNDmswkHXrvDzc93ZFTkTUXDfme903y5X2ZHVlnIcteo_IcoYZeBFThhhUlaoqyobhon2UniNWsoDXCRwfz4-wshG2ZvqoqS0peZMe4ZTVirD3Jfl-HADZqYXLvDOSuyxd3t3Rxi3OwXstNn6q5trkUD-CMgAuj77XKvehi3mvpnXK90DbknfN53EBi1SCjdnb0sjB4Z5O50l0HfrfTvhYi9LkEY8Kr7HknTICzx_9p9v3j9d3V5-Lmy6fl1eKmkKyksVCrFbRISqwoaxnrGqQYrhnqVkzWFaKykjUmQjAgDbSqJTXFpaQSi0a1aoWq02w5-Sontvze6174X9wJzXcLzq-58FFLA5ygBpK0paSSRFCyaiomS1ZLSklXkjZ5XU5e98OqByXT1bwwM9N5xeoNX7sHXrekYbRJBu8fDbz7MUCIvNdhbIew4IbAcVk1mGG82-vthK5FOpq2nUuOcsT5oiaUIEooTtT5f6g0FKSHSuHpdFqfCT7MBImJ8DOuxRACX377OmffHbAbECZugjPD-JhhDr457MvfhuwjlwA2ASk7IXjouNRxF4p0XG04KvmYbz7lm6d88zHffFSif5R786c0eNKExNo1eL51g0-JDE-I_gBZMAsH |
CitedBy_id | crossref_primary_10_1093_function_zqad043 crossref_primary_10_3390_membranes11110844 crossref_primary_10_1007_s00432_021_03793_2 crossref_primary_10_1016_j_ebiom_2020_103161 crossref_primary_10_1113_JP284807 crossref_primary_10_4103_1673_5374_250630 crossref_primary_10_3389_fnmol_2020_00150 crossref_primary_10_1186_s12860_019_0225_0 crossref_primary_10_4103_1673_5374_241428 crossref_primary_10_1186_s13018_021_02598_w crossref_primary_10_1515_revneuro_2020_0013 |
Cites_doi | 10.1073/pnas.182296499 10.1371/journal.pone.0127266 10.1016/j.neuint.2011.05.019 10.3109/07853890903321567 10.1073/pnas.1602397113 10.1177/1470320316666750 10.1113/expphysiol.2008.041988 10.1016/j.celrep.2015.01.049 10.1038/sj.bjc.6604508 10.1093/hmg/ddv380 10.1073/pnas.95.17.10257 10.1083/jcb.201002049 10.1074/jbc.M205664200 10.1074/jbc.274.18.12702 10.1093/hmg/ddi094 10.1097/ICO.0000000000001228 10.1172/JCI200317977 10.1371/journal.pone.0133181 10.1159/000092097 10.1016/j.devcel.2008.04.015 10.1093/hmg/ddt180 10.1002/stem.210 10.1371/journal.pone.0069440 10.1111/j.1471-4159.2007.05109.x 10.1007/s00125-012-2702-2 10.2174/138920312800493160 10.1002/prca.200700522 10.1113/JP270590 10.1002/ana.10051 10.1523/JNEUROSCI.1647-07.2007 10.1093/embo-reports/kvf008 10.1016/S0006-8993(98)00498-3 10.1074/jbc.M002020200 10.1016/j.ijdevneu.2012.09.004 10.1523/JNEUROSCI.4130-14.2015 10.1091/mbc.e13-12-0730 10.1002/0471143030.cb0322s30 10.1152/ajpregu.90832.2008 10.1681/ASN.2007091030 10.1002/mds.23085 10.1016/S0898-6568(03)00070-6 10.1126/science.1179802 10.1172/JCI0214276 10.1016/j.mcn.2010.11.004 10.1016/j.devcel.2006.07.003 10.2741/E631 10.1016/j.mcn.2005.12.003 10.1016/j.bbadis.2015.08.010 10.1161/01.HYP.0000248211.82232.a7 10.1126/science.1153124 10.1016/j.neulet.2004.04.002 10.1002/dneu.20559 10.1007/s00018-010-0447-y 10.1016/j.bbr.2011.04.022 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S 10.1091/mbc.12.10.3031 10.1371/journal.pone.0022901 |
ContentType | Journal Article |
Copyright | The Author(s). 2018 COPYRIGHT 2018 BioMed Central Ltd. |
Copyright_xml | – notice: The Author(s). 2018 – notice: COPYRIGHT 2018 BioMed Central Ltd. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 7X8 5PM DOA |
DOI | 10.1186/s13287-018-0862-9 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1757-6512 |
EndPage | 24 |
ExternalDocumentID | oai_doaj_org_article_418ec6c9643c4a64b837c075c664f049 PMC5948768 A546416462 29751779 10_1186_s13287_018_0862_9 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: CEDRE grantid: 35399WH – fundername: Lebanese Universitry grantid: MENESER – fundername: ; grantid: MENESER – fundername: ; grantid: 35399WH |
GroupedDBID | --- 0R~ 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFS ACIHN ACJQM ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU DIK E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IEA IHR IHW INH INR ISR ITC KQ8 LK8 M1P M7P M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SBL SOJ SV3 TUS UKHRP AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 7X8 5PM |
ID | FETCH-LOGICAL-c706t-dbbe91cc2d67977f81d72571fb7c5316c3c524aa7e48e9d945620c6c2a8d9db13 |
IEDL.DBID | C6C |
ISSN | 1757-6512 |
IngestDate | Wed Aug 27 01:20:14 EDT 2025 Thu Aug 21 13:52:01 EDT 2025 Fri Sep 05 09:55:48 EDT 2025 Tue Jun 17 21:01:56 EDT 2025 Tue Jun 10 20:29:13 EDT 2025 Fri Jun 27 04:40:11 EDT 2025 Thu May 22 21:23:49 EDT 2025 Mon Jul 21 06:05:49 EDT 2025 Tue Jul 01 00:43:19 EDT 2025 Thu Apr 24 22:53:37 EDT 2025 Sat Sep 06 07:28:32 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Wnt signaling Renin Caveolae Neural differentiation Caveolin Flotillin ATP6AP2 Stem cells Lipid rafts Exosomes |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c706t-dbbe91cc2d67977f81d72571fb7c5316c3c524aa7e48e9d945620c6c2a8d9db13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7240-0968 |
OpenAccessLink | https://doi.org/10.1186/s13287-018-0862-9 |
PMID | 29751779 |
PQID | 2038272249 |
PQPubID | 23479 |
PageCount | 24 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_418ec6c9643c4a64b837c075c664f049 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5948768 proquest_miscellaneous_2038272249 gale_infotracmisc_A546416462 gale_infotracacademiconefile_A546416462 gale_incontextgauss_ISR_A546416462 gale_healthsolutions_A546416462 pubmed_primary_29751779 crossref_citationtrail_10_1186_s13287_018_0862_9 crossref_primary_10_1186_s13287_018_0862_9 springer_journals_10_1186_s13287_018_0862_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-05-11 |
PublicationDateYYYYMMDD | 2018-05-11 |
PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Stem cell research & therapy |
PublicationTitleAbbrev | Stem Cell Res Ther |
PublicationTitleAlternate | Stem Cell Res Ther |
PublicationYear | 2018 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | S Wang (862_CR47) 2013; 31 G Nguyen (862_CR40) 2010; 42 Y Li (862_CR14) 2011; 6 H Yamamoto (862_CR55) 2006; 11 F Galbiati (862_CR15) 1998; 95 K Trajkovic (862_CR58) 2008; 319 R Haque (862_CR12) 2015; 21 J Zschocke (862_CR16) 2002; 277 P Hedera (862_CR43) 2002; 51 A Chairoungdua (862_CR22) 2010; 190 Z Shan (862_CR4) 2008; 93 J Egawa (862_CR19) 2016; 594 C Wang (862_CR33) 2013; 8 H Yamamoto (862_CR54) 2008; 15 D Volonté (862_CR46) 1999; 274 M Boulware (862_CR17) 2007; 27 T Ikezu (862_CR48) 1998; 804 A Dubos (862_CR7) 2015; 24 C Stern (862_CR13) 2010; 67 P Poorkaj (862_CR41) 2010; 25 G Sihn (862_CR45) 2013; 5 C Lange (862_CR31) 2006; 3 J Ramser (862_CR42) 2005; 14 C D’Orlando (862_CR18) 2008; 104 G Lachenal (862_CR36) 2011; 46 Y Li (862_CR35) 2011; 59 C Stuermer (862_CR21) 2001; 12 N Al-Makdissy (862_CR56) 2003; 15 J Han (862_CR10) 2015; 10 A Taylor (862_CR39) 2007; 67 J Fauré (862_CR37) 2006; 31 G Nguyen (862_CR3) 2002; 109 S Schafer (862_CR34) 2015; 35 A Kanda (862_CR11) 2012; 55 N Makdissy (862_CR27) 2015; 10 C Cruciat (862_CR8) 2010; 327 D Lang (862_CR20) 1998; 37 A Contrepas (862_CR5) 2009; 297 F Galbiati (862_CR49) 2000; 275 K Matsushita (862_CR1) 2006; 48 J Alio Del Barrio (862_CR26) 2017; 36 E Krämer-Albers (862_CR38) 2007; 1 S Feldt (862_CR30) 2008; 19 K Jin (862_CR52) 2002; 99 O Korvatska (862_CR6) 2013; 22 K Yoshinaka (862_CR24) 2004; 363 L C̆ajánek (862_CR53) 2009; 27 862_CR44 N Fournier (862_CR50) 2012; 227 Y Sun (862_CR51) 2003; 111 B Beckermann (862_CR9) 2008; 99 Q He (862_CR57) 2014; 25 J AlBacha (862_CR25) 2015; 10 C Théry (862_CR28) 2006; 3 X Lu (862_CR29) 2016; 113 H Yamanaka (862_CR32) 2002; 3 H Lu (862_CR59) 2008; 118 E Jansen (862_CR2) 2012; 13 K Essandoh (862_CR23) 2015; 1852 |
References_xml | – volume: 99 start-page: 11946 issue: 18 year: 2002 ident: 862_CR52 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.182296499 – volume: 10 start-page: e0127266 issue: 5 year: 2015 ident: 862_CR25 publication-title: PLoS One doi: 10.1371/journal.pone.0127266 – volume: 59 start-page: 114 issue: 2 year: 2011 ident: 862_CR35 publication-title: Neurochem Int doi: 10.1016/j.neuint.2011.05.019 – volume: 42 start-page: 13 issue: 1 year: 2010 ident: 862_CR40 publication-title: Ann Med doi: 10.3109/07853890903321567 – volume: 113 start-page: E1898 year: 2016 ident: 862_CR29 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1602397113 – ident: 862_CR44 doi: 10.1177/1470320316666750 – volume: 93 start-page: 701 issue: 5 year: 2008 ident: 862_CR4 publication-title: Exp Physiol doi: 10.1113/expphysiol.2008.041988 – volume: 10 start-page: 1158 issue: 7 year: 2015 ident: 862_CR10 publication-title: Cell Rep doi: 10.1016/j.celrep.2015.01.049 – volume: 99 start-page: 622 issue: 4 year: 2008 ident: 862_CR9 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604508 – volume: 24 start-page: 6736 issue: 23 year: 2015 ident: 862_CR7 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddv380 – volume: 95 start-page: 10257 issue: 17 year: 1998 ident: 862_CR15 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.17.10257 – volume: 190 start-page: 1079 issue: 6 year: 2010 ident: 862_CR22 publication-title: J Cell Biol doi: 10.1083/jcb.201002049 – volume: 277 start-page: 38772 issue: 41 year: 2002 ident: 862_CR16 publication-title: J Biol Chem doi: 10.1074/jbc.M205664200 – volume: 118 start-page: 984 issue: 3 year: 2008 ident: 862_CR59 publication-title: J Clin Invest – volume: 274 start-page: 12702 issue: 18 year: 1999 ident: 862_CR46 publication-title: J Biol Chem doi: 10.1074/jbc.274.18.12702 – volume: 14 start-page: 1019 issue: 8 year: 2005 ident: 862_CR42 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddi094 – volume: 36 start-page: 952 issue: 8 year: 2017 ident: 862_CR26 publication-title: Cornea doi: 10.1097/ICO.0000000000001228 – volume: 111 start-page: 1843 issue: 12 year: 2003 ident: 862_CR51 publication-title: J Clin Invest doi: 10.1172/JCI200317977 – volume: 10 start-page: e0133181 issue: 7 year: 2015 ident: 862_CR27 publication-title: PLoS One doi: 10.1371/journal.pone.0133181 – volume: 3 start-page: 76 issue: 1–2 year: 2006 ident: 862_CR31 publication-title: Neurodegener Dis doi: 10.1159/000092097 – volume: 15 start-page: 37 issue: 1 year: 2008 ident: 862_CR54 publication-title: Dev Cell doi: 10.1016/j.devcel.2008.04.015 – volume: 22 start-page: 3259 issue: 16 year: 2013 ident: 862_CR6 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddt180 – volume: 27 start-page: 2917 issue: 12 year: 2009 ident: 862_CR53 publication-title: Stem Cells doi: 10.1002/stem.210 – volume: 8 start-page: e69440 issue: 7 year: 2013 ident: 862_CR33 publication-title: PLoS One doi: 10.1371/journal.pone.0069440 – volume: 104 start-page: 1577 issue: 6 year: 2008 ident: 862_CR18 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.05109.x – volume: 55 start-page: 3104 issue: 11 year: 2012 ident: 862_CR11 publication-title: Diabetologia doi: 10.1007/s00125-012-2702-2 – volume: 13 start-page: 124 issue: 2 year: 2012 ident: 862_CR2 publication-title: Curr Protein Pept Sci doi: 10.2174/138920312800493160 – volume: 1 start-page: 1446 issue: 11 year: 2007 ident: 862_CR38 publication-title: Proteomics Clin Appl doi: 10.1002/prca.200700522 – volume: 594 start-page: 4565 issue: 16 year: 2016 ident: 862_CR19 publication-title: J Physiol doi: 10.1113/JP270590 – volume: 51 start-page: 45 issue: 1 year: 2002 ident: 862_CR43 publication-title: Ann Neurol doi: 10.1002/ana.10051 – volume: 27 start-page: 9941 issue: 37 year: 2007 ident: 862_CR17 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1647-07.2007 – volume: 3 start-page: 69 issue: 1 year: 2002 ident: 862_CR32 publication-title: EMBO Rep doi: 10.1093/embo-reports/kvf008 – volume: 804 start-page: 177 issue: 2 year: 1998 ident: 862_CR48 publication-title: Brain Res doi: 10.1016/S0006-8993(98)00498-3 – volume: 275 start-page: 23368 issue: 30 year: 2000 ident: 862_CR49 publication-title: J Biol Chem doi: 10.1074/jbc.M002020200 – volume: 31 start-page: 30 issue: 1 year: 2013 ident: 862_CR47 publication-title: Int J Dev Neurosci doi: 10.1016/j.ijdevneu.2012.09.004 – volume: 35 start-page: 4983 issue: 12 year: 2015 ident: 862_CR34 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4130-14.2015 – volume: 25 start-page: 1715 issue: 11 year: 2014 ident: 862_CR57 publication-title: Mol Biol Cell doi: 10.1091/mbc.e13-12-0730 – volume: 3 start-page: 3.22 year: 2006 ident: 862_CR28 publication-title: Curr Protoc Cell Biol doi: 10.1002/0471143030.cb0322s30 – volume: 297 start-page: R250 issue: 2 year: 2009 ident: 862_CR5 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.90832.2008 – volume: 19 start-page: 743 issue: 4 year: 2008 ident: 862_CR30 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2007091030 – volume: 25 start-page: 1409 issue: 10 year: 2010 ident: 862_CR41 publication-title: Mov Disord Off J Mov Disord Soc doi: 10.1002/mds.23085 – volume: 15 start-page: 1019 issue: 11 year: 2003 ident: 862_CR56 publication-title: Cell Signal doi: 10.1016/S0898-6568(03)00070-6 – volume: 327 start-page: 459 issue: 5964 year: 2010 ident: 862_CR8 publication-title: Science doi: 10.1126/science.1179802 – volume: 109 start-page: 1417 issue: 11 year: 2002 ident: 862_CR3 publication-title: J Clin Invest doi: 10.1172/JCI0214276 – volume: 46 start-page: 409 issue: 2 year: 2011 ident: 862_CR36 publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2010.11.004 – volume: 21 start-page: 224 year: 2015 ident: 862_CR12 publication-title: Mol Vis – volume: 11 start-page: 213 issue: 2 year: 2006 ident: 862_CR55 publication-title: Dev Cell doi: 10.1016/j.devcel.2006.07.003 – volume: 5 start-page: 500 year: 2013 ident: 862_CR45 publication-title: Front Biosci (Elite Ed) doi: 10.2741/E631 – volume: 31 start-page: 642 issue: 4 year: 2006 ident: 862_CR37 publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2005.12.003 – volume: 1852 start-page: 2362 issue: 11 year: 2015 ident: 862_CR23 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbadis.2015.08.010 – volume: 48 start-page: 1095 issue: 6 year: 2006 ident: 862_CR1 publication-title: Hypertension doi: 10.1161/01.HYP.0000248211.82232.a7 – volume: 319 start-page: 1244 issue: 5867 year: 2008 ident: 862_CR58 publication-title: Science doi: 10.1126/science.1153124 – volume: 363 start-page: 168 issue: 2 year: 2004 ident: 862_CR24 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.04.002 – volume: 67 start-page: 1815 issue: 13 year: 2007 ident: 862_CR39 publication-title: Dev Neurobiol doi: 10.1002/dneu.20559 – volume: 67 start-page: 3785 issue: 22 year: 2010 ident: 862_CR13 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-010-0447-y – volume: 227 start-page: 440 issue: 2 year: 2012 ident: 862_CR50 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2011.04.022 – volume: 37 start-page: 502 issue: 4 year: 1998 ident: 862_CR20 publication-title: J Neurobiol doi: 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S – volume: 12 start-page: 3031 issue: 10 year: 2001 ident: 862_CR21 publication-title: Mol Biol Cell doi: 10.1091/mbc.12.10.3031 – volume: 6 start-page: e22901 issue: 8 year: 2011 ident: 862_CR14 publication-title: PLoS One doi: 10.1371/journal.pone.0022901 |
SSID | ssj0000330064 |
Score | 2.2118845 |
Snippet | Background
The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2... The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that ATP6AP2 expression... Abstract Background The subcellular distribution of prorenin receptor and adaptor protein ATP6AP2 may affect neurogenesis. In this study, we hypothesized that... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 132 |
SubjectTerms | ATP6AP2 Biomedical and Life Sciences Biomedical Engineering and Bioengineering Caveolae Caveolae - metabolism Caveolin Cell Biology Cell differentiation Exosomes Flotillin Humans Life Sciences Lipid rafts Middle Aged Neurons Receptors, Cell Surface - metabolism Regenerative Medicine/Tissue Engineering Signal Transduction Stem Cells Stem Cells - metabolism Vacuolar Proton-Translocating ATPases - metabolism |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-kIPgifntadRVBUEKzm80m-3hKSxWUoi30bdlPG7BJaXKC7_7hzmRzx6WivvianbskM7PzkZ35DSEvOZhDXpUxy6U1mTDRZKZ2PotFWXiwf6HMsVH44yd5eCI-nJanW6O-sCYswQMnxu0JVgcnHcJGOWGksJBROfBzTkoRIbxF6ws-byuZGm0wpOngbKdjTFbLvR7SrhqrLBGQWfJMzRzRiNf_u1XecktXSyavnJuO7ujgFrk5xZF0mZ7_NrkW2jvkepos-eMu-bnfY1cRKBfF-kHaRbo8PpLLI05BYRp3hh8FadNSZ74HyG6xzuSi8fTSxIGeY5Ge785N0_YUgloKQSLQ-gQ0i_81omDi_dfzVYYkYVxDZGiK5wH9PXJysH_87jCbBi5krsrlkHlrg2LOcS8riAsjxLIVbGkWbeVgr0pXuJILY6og6qC8wuwpB-FwU3vlLSvuk522a8NDQl1kTpReQYRVCGWCjdYVlnkVFNCVYkHyNfe1m9DIcSjGNz1mJbXUSWAaBKZRYFotyOvNTy4SFMffiN-iSDeEiKI9XgDd0pNu6X_p1oI8Q4XQqSV1Ywv0shRSIDAbX5AXIwUiabRYqvPVrPpev__yeUb0aiKKHbyjM1PnA3AKwbdmlLszStjqbrb8fK2ZGpewPq4N3arXPC9qXkE4Bs_8IGnq5tWxd5pVFaxUMx2e8Wa-0jZnI9I4YvlAProgb9baricT1_-Z9Y_-B-sfkxt83Ktlxtgu2RkuV-EJhH-DfTru9F9m_FSV priority: 102 providerName: Directory of Open Access Journals |
Title | Essential role of ATP6AP2 enrichment in caveolae/lipid raft microdomains for the induction of neuronal differentiation of stem cells |
URI | https://link.springer.com/article/10.1186/s13287-018-0862-9 https://www.ncbi.nlm.nih.gov/pubmed/29751779 https://www.proquest.com/docview/2038272249 https://pubmed.ncbi.nlm.nih.gov/PMC5948768 https://doaj.org/article/418ec6c9643c4a64b837c075c664f049 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF9si-CL-G20nqsIghJMNpvd5PFarlTBctQW7m3Z7IcN2KQ0uULf_cOdSXKhqR_ga2bytTOzO7Mz81tC3jGYDplMfRiJQodcex3qzNjQJ2liYf5zaYSNwl-PxOEp_7JKVwNYNPbC3Mzfx5n41EC0lGFxJOIoCxbmW2QnRZgxzMuK_XE7JYK4HFbXIW_5xzsnK08H0P_7NHxjHbpdI3krUdqtPwcPyP3BcaTzXtIPyR1XPSJ3-6Mkrx-Tn4sG24hAmygWDNLa0_nJUsyXjIKGlOYMdwFpWVGjrxyEs1hYclFaeql9S8-xKs_W57qsGgpeLAWvEHhtjyyLz-pgL_H9mwNV2l6kSEMoaIoJgOYJOT1YnOwfhsMJC6GRkWhDWxQuj41hVkhwBD04rxJsOPaFNGCcwiQmZVxr6XjmcptjuBQZYZjObG6LOHlKtqu6cs8JNT42PLU5uFQJz7UrfGGSIra5y4Ev5QGJNqOvzAA_jqdg_FBdGJIJ1QtMgcAUCkzlAfkw3nLRY2_8i3kPRToyImx2dwG0SQ1WqHicOfh8xCAzXAteQHhuwGkyQnAPsVJAXqNCqL4HdTR-NU-54IjExgLytuNA6IwKa3O-63XTqM_fjidM7wcmX8M_Gj20OsBIIdrWhHN3wgm2bSbkNxvNVEjCgrjK1etGsSjJmAT_C775Wa-p469js3QsJVDkRIcnYzOlVOVZBy2O4D0QgAbk40bb1TCnNX8f-hf_xf2S3GOdUaZhHO-S7fZy7V6BY9cWM7IlV3JGdvYWR8vjWWfgs26T5BchAUkI |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagCMEF8SZQqEFISKCIxHGc-LhUrbbQVhVspd4sxw8aiSZVk0Xizg9nxsmumvKQuK6_ZBPPjD2TmflMyGsGyyErch8notIx117HujQ29lmeWVj_XJ5go_DBoZgf848n-clIFo29MJfz92kp3ncQLZVYHIk8yoLF8jq5wSFQDnlZsb3-nJJAXA6765i3_OOVk50nEPT_vgxf2oeu1kheSZSG_Wf3LrkzOo50Nkj6Hrnmmvvk5nCU5I8H5OdOh21EoE0UCwZp6-lscSRmR4yChtTmFL8C0rqhRn93EM5iYcl5bemF9j09w6o8257puukoeLEUvELA2oFZFu8VaC_x_1cHqvSDSHEMqaApJgC6h-R4d2exPY_HExZiUySij21VOZkaw6wowBH04LwWYMOprwoDxilMZnLGtS4cL520EsOlxAjDdGmlrdLsEdlo2sY9IdT41PDcSnCpMi61q3xlsiq10knA5TwiyWr2lRnpx_EUjG8qhCGlUIPAFAhMocCUjMjb9SXnA_fGv8AfUKRrINJmhx9Am9RohYqnpYPHRw4yw7XgFYTnBpwmIwT3ECtFZAsVQg09qGvjV7OcC45MbCwirwICqTMarM35qpddp_a-fJ6A3owg38I7Gj22OsBMIdvWBLk5QYJtm8nwy5VmKhzCgrjGtctOsSQrWQH-Fzzz40FT16-OzdJpUcBIMdHhydxMR5r6NFCLI3kPBKARebfSdjWuad3fp_7pf6G3yK354mBf7e8dfnpGbrNgoHmcpptko79Yuufg5PXVi2DevwD_DUh_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ra9RAEF_0iuKX4tvUalcRBCU02Ww2yceoPdpTy2Fb6Ldls4_2wCbHJSf43T_cmTwOUx_g15tJLtl57Ex25jeEvGLgDlkSOz8QhfK5cspXqTa-i-LIgP-zcYCNwp-PxeEZn53H5_2c03qodh-OJLueBkRpKpv9pXGdiadiv4YcKsWSSURXFszPbpKtVED0MCFbeT47mW0-swSQr8Ou259n_vHa0Y7UAvf_7p5_2Z-u105eO0Bt96XpXbLdB5Q07zTgHrlhy_vkVjdi8vsD8uOgxvYi0DKKhYS0cjQ_nYt8zihozkJf4tdBuiipVt8spLlYcLJcGLpSrqFXWK1nqiu1KGsK0S2FaBF4TYc4i_dq4TDx_4dBK00naqQhRDTFg4H6ITmbHpy-P_T7yQu-TgLR-KYobBZqzYxIIEB0ENQmYNuhKxINRit0pGPGlUosT21mMkyjAi00U6nJTBFGj8ikrEr7hFDtQs1jk0GoFfFM2cIVOipCk9kM-GLukWBYfal7WHKcjvFVtulJKmQnMAkCkygwmXnkzeaSZYfJ8S_mdyjSDSPCabc_VKsL2Vun5GFq4fERm0xzJXgBabuGYEoLwR3kUB7ZQ4WQXW_qxinIPOaCI0Ib88jLlgMhNUqs2blQ67qWRydfRkyveyZXwTtq1bdAwEohCteIc3fECTavR-QXg2ZKJGGhXGmrdS1ZEKUsgbgMnvlxp6mbV8cm6jBJgJKMdHi0NmNKubhsIccR1AcSU4-8HbRd9r6u_vvS7_wX9x65Pf8wlZ-Ojj8-JXdYa5-xH4a7ZNKs1vYZxH5N8by3758eklIt |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Essential+role+of+ATP6AP2+enrichment+in+caveolae%2Flipid+raft+microdomains+for+the+induction+of+neuronal+differentiation+of+stem+cells&rft.jtitle=Stem+cell+research+%26+therapy&rft.au=Makdissy%2C+Nehman&rft.au=Haddad%2C+Katia&rft.au=AlBacha%2C+Jeanne+D%27arc&rft.au=Chaker%2C+Diana&rft.date=2018-05-11&rft.pub=BioMed+Central+Ltd&rft.issn=1757-6512&rft.eissn=1757-6512&rft.volume=9&rft.issue=1&rft_id=info:doi/10.1186%2Fs13287-018-0862-9&rft.externalDocID=A546416462 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-6512&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-6512&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-6512&client=summon |